Genetix to Acquire Applied Imaging

Applied Imaging Corp. (San Jose, CA, USA), a supplier of automated microscopy imaging and image-analysis systems, has agreed to be acquired by the Genetix Group (New Milton, UK) in an all-cash transaction valued at U.S.$18.3 million. The deal is expected to close in the fourth quarter of 2006.

Genetix is a cell biology, proteomics, and genomics health technology group that designs, develops, and manufactures innovative systems that reduce the time and cost of introducing new biopharmaceuticals. Its products include instruments and consumables that were used in the Human Genome Project and are now used in the genetic analysis of human diseases, analyzing and selecting cells for the production of therapeutic proteins.

Applied Imaging supplies imaging and image analysis systems for fluorescence and brightfield microscopy. It is developing a system for detecting, quantifying, and characterizing circulating tumor cells in the blood of cancer patients.

"This proposed acquisition is consistent with our strategy to broaden and strengthen our capabilities in cell imaging and analysis. By diversifying our product portfolio and building our U.S. presence, we will be better able to address global growth opportunities in the drug discovery and clinical diagnostics markets. Genetix's cell biology instruments and reagents complement Applied Imaging's imaging and image analysis systems and will help both companies to expand in the United States, Europe, and Asia,” said Mark Reid, CEO of Genetix.



Related Links:
Applied Imaging
Genetix Group